145 related articles for article (PubMed ID: 19461251)
1. Malignant melanoma with monster cells showing massive cyclin D1 amplification.
Pouryazdanparast P; Newman M; Mafee M; Guitart J; Gerami P
Am J Dermatopathol; 2009 Jun; 31(4):402-3. PubMed ID: 19461251
[No Abstract] [Full Text] [Related]
2. Cyclin D1 is a candidate oncogene in cutaneous melanoma.
Sauter ER; Yeo UC; von Stemm A; Zhu W; Litwin S; Tichansky DS; Pistritto G; Nesbit M; Pinkel D; Herlyn M; Bastian BC
Cancer Res; 2002 Jun; 62(11):3200-6. PubMed ID: 12036934
[TBL] [Abstract][Full Text] [Related]
3. 'Monster cell' melanoma with pulmonary metastasis and cyclin D1 amplification.
Hawryluk EB; Baran JL; Gerami P; Sepehr A
J Cutan Pathol; 2013 Jan; 40(1):61-5. PubMed ID: 23278726
[TBL] [Abstract][Full Text] [Related]
4. Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.
Nai G; Marques M
Pathol Res Pract; 2011 Mar; 207(3):174-81. PubMed ID: 21300445
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
6. Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.
Utikal J; Udart M; Leiter U; Peter RU; Krähn G
Int J Oncol; 2005 Mar; 26(3):597-605. PubMed ID: 15703813
[TBL] [Abstract][Full Text] [Related]
7. Homogeneous staining regions for cyclin D1, a marker of poor prognosis in malignant melanoma.
Gammon B; Ali L; Guitart J; Gerami P
Am J Dermatopathol; 2012 Jul; 34(5):487-90. PubMed ID: 22456513
[TBL] [Abstract][Full Text] [Related]
8. No evidence for ErbB4 gene amplification in malignant melanoma.
Brockhoff G; Bock M; Gantner S; Hafner C
Acta Derm Venereol; 2011 Jun; 91(4):488-90. PubMed ID: 21547347
[No Abstract] [Full Text] [Related]
9. Cyclin D1 homogeneous staining regions by fluorescent in situ hybridization: a possible indicator of aggressive behavior in melanomas.
Gerami P; Guitart J; Martini M; Wayne JD; Kuzel T
Arch Dermatol; 2008 Sep; 144(9):1235-6. PubMed ID: 18794480
[No Abstract] [Full Text] [Related]
10. EGFR in melanoma: clinical significance and potential therapeutic target.
Boone B; Jacobs K; Ferdinande L; Taildeman J; Lambert J; Peeters M; Bracke M; Pauwels P; Brochez L
J Cutan Pathol; 2011 Jun; 38(6):492-502. PubMed ID: 21352258
[TBL] [Abstract][Full Text] [Related]
11. An Unusual Case of Desmoplastic Melanoma With Monster Cells Imitating an Atypical Fibroxanthoma.
Ríos-Martín JJ; Pérez-Pérez M; Umbría-Jiménez S; Moreno-Ramírez D; Vallejo-Benítez A
Int J Surg Pathol; 2022 May; 30(3):313-316. PubMed ID: 34541940
[TBL] [Abstract][Full Text] [Related]
12. CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.
Liu J; Yu W; Gao F; Qi S; Du J; Ma X; Zhang Y; Zheng J; Su J
Diagn Pathol; 2021 Jul; 16(1):60. PubMed ID: 34225728
[TBL] [Abstract][Full Text] [Related]
13. Lack of associations of selected variants in genes involved in cell cycle and apoptosis with skin cancer risk.
Han J; Colditz GA; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):592-3. PubMed ID: 16537723
[No Abstract] [Full Text] [Related]
14. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K
Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926
[TBL] [Abstract][Full Text] [Related]
15. An update on the implications of cyclin D1 in melanomas.
González-Ruiz L; González-Moles MÁ; González-Ruiz I; Ruiz-Ávila I; Ayén Á; Ramos-García P
Pigment Cell Melanoma Res; 2020 Nov; 33(6):788-805. PubMed ID: 32147907
[TBL] [Abstract][Full Text] [Related]
16. [A silent-growing and fast-killing melanoma in a teenager].
Uguen A; Talagas M; Quintin-Roué I; Abasq C; Coat C; Charles-Pétillon F; De Braekeleer M; Marcorelles P
Ann Pathol; 2012 Aug; 32(4):254-8. PubMed ID: 23010398
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 gene amplification in proliferating haemangioma.
Mohamed AM; Elwakil TF; Taher IM; Elbarbary MM; Kayed HF; Hussein HA; Eid OM
Cell Tissue Res; 2009 Oct; 338(1):107-15. PubMed ID: 19823825
[TBL] [Abstract][Full Text] [Related]
18. Mantle cell lymphoma with triple-fusion signals of immunoglobulin heavy chain locus/cyclin D1 gene by fluorescence in situ hybridization.
Kuroda N; Taniguchi Y; Miyazaki E; Inagaki K
Pathol Int; 2006 Aug; 56(8):478-9. PubMed ID: 16872445
[No Abstract] [Full Text] [Related]
19. Congenital malignant melanoma: a case report with cytogenetic studies.
Singh K; Moore S; Sandoval M; Balzer B; Frishberg D; Lewin S; Schreck R; Raffel L
Am J Dermatopathol; 2013 Dec; 35(8):e135-8. PubMed ID: 23907318
[TBL] [Abstract][Full Text] [Related]
20. Early cancers of the skin: clinical, histopathological, and molecular characteristics.
Takata M; Saida T
Int J Clin Oncol; 2005 Dec; 10(6):391-7. PubMed ID: 16369742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
